IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Actavis to sell operations in seven European countries to Aurobindo

11:37 AM MST | January 20, 2014 | Deepti Ramesh

Aurobindo Pharma (Hyderabad, India) says it will acquire the commercial operations of Actavis (Dublin) in seven Western European countries. Aurobindo will acquire Actavis' pharmaceutical commercial infrastructure in Belgium, France, Germany, Italy, the Netherlands, Portugal, and Spain, including products, marketing authorizations, and dossier license rights. The two companies will also enter into a long-term strategic supply arrangement. Financial details of the deal have not been disclosed. Management estimates the net sales for the acquired businesses would be...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa